S301: GERMAN AMLCG-SURVIVORSHIP STUDY: QUALITY OF LIFE AND LIFE SATISFACTION IN AML LONG-TERM SURVIVORS by E. Telzerow, D. Görlich, C. Sauerland, A. S. Moret, M. Rothenberg-Thurley, F. H. A. Mumm, S. Amler, W. E. Berdel, B. Wörmann, U. Krug, J. Braess, P. Heussner, W. Hiddemann, K. Spiekermann, K. H. Metzeler

Get full text

P558: GERMAN AMLCG-SURVIVORSHIP STUDY – SOMATIC LONG-TERM CONSEQUENCE OF AML AND ITS THERAPY: FROM HEART TO KIDNEY. by A. S. Moret, E. Telzerow, C. Sauerland, M. Rothenberg-Thurley, F. H. A. Mumm, J. Braess, B. Wörmann, U. Krug, W. E. Berdel, W. Hiddemann, K. Spiekermann, P. Heußner, K. Kraywinkel, D. Görlich, K. H. Metzeler

Get full text

P416: CLONAL HEMATOPOIESIS IS COMMON IN AML LONG-TERM SURVIVORS AND MAY ASSOCIATE WITH DIABETES AND SECONDARY NEOPLASIAS, BUT NOT OTHER HEALTH OUTCOMES by S. M. Krauß, E. Telzerow, A. S. Moret, D. Richter, M. Rothenberg-Thurley, D. Görlich, M. C. Sauerland, W. E. Berdel, B. Wörmann, U. Krug, J. Braess, P. Heussner, W. Enard, W. Hiddemann, K. Spiekermann, U. Platzbecker, K. H. Metzeler

Get full text

S206: OBINUTUZUMAB PLUS CHEMOTHERAPY DEMONSTRATES LONG-TERM BENEFIT OVER RITUXIMAB PLUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: FINAL ANALYSIS OF TH... by W. Townsend, W. Hiddemann, C. Buske, G. Cartron, D. Cunningham, M. J. Dyer, J. Gribben, E. Phillips, M. Dreyling, J. F. Seymour, A. Grigg, T.-Y. Lin, X.-N. Hong, D. Kingbiel, T. G. Nielsen, A. Knapp, M. Herold, R. Marcus

Get full text

P479: DNA METHYLATION PROFILING REFINES THE PROGNOSTIC CLASSIFICATION OF ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH INTENSIVE CHEMOTHERAPY by S. Vosberg, A. Ohnmacht, C. Moser, A. Arneth, V. Jurinovic, K. H. Metzeler, M. C. Sauerland, D. Görlich, W. E. Berdel, J. Braess, S. Amler, U. Krug, W. Hiddemann, K. Spiekermann, C. C. Oakes, M. P. Menden, T. Herold, P. A. Greif

Get full text